深圳市某三级综合医院临床路径实施效果评价

目的 评价临床路径管理模式的临床效果.方法 选取该医院2010年5月-2013年5月5个实施临床路径管理病种的患者5268例（临床路径组）和同期的非临床路径管理患者5895例（传统组）,对次均住院费用、平均住院日、术前平均住院日及患者满意度等指标进行综合评价.结果 临床路径组与传统组比较：结节性甲状腺肿的次均住院费用、次均药费差异无统计学意义,P＞0.05,但辅助检查费用显著下降,P＜0.001;单纯性阑尾炎次均辅助检查费用差异无统计学意义,P=0.749;其余病种次均住院费用、平均住院日、术前平均住院日和患者满意度比较,P值均＜0.05,差异有统计学意义.结论 临床路径管理可以有效控制医疗费用的过快增长,缩短患者住院时间和术前等待时间,提高患者满意度.

Effect Evaluation of Clinical Pathway in A tertiary General Hospital in Shenzhen

Objective To evaluate the clinical effects of clinical pathway management mode. Methods Comparing and evaluating indexes of hospital charge, hospital stays, pre-operative hospital stays and the ratio of patient satisfaction in two groups. One included 5268 cases of clinical pathway management （clinical-pathway group） and the other group included 5895 cases of non-clinical pathway management （traditional group）. Results The differences of hospital charge, hospital stays, pre-operative hospital stays and the ratio of patient satisfaction were all statistically significant （P〈0. 05） between the two groups except the average hospitalization expense and medicine expense in nodular goiter（p 〉 0.05） and the average assistant examination expense in acute simple appendicitis （p=0. 749）, meanwhile, the assistant examination expense was significantly decreased in the clinical pathway management group in nodular goiter（p〈0. 001）. Conclusion Clinical pathway can control inpatient expense growth, shorten inpatient time and pre-operative hospital stays and improve patient satisfaction effectively.